DHA dosage and pregnancy
1. Predicting the effect of maternal docosahexaenoic acid (DHA) supplementation to reduce early preterm birth in Australia and the United States using results of within country randomized controlled trials. (Studies: 800 mg/day and 600 mg/day) -> |
![]()
|
2. Dose–response relationship between docosahexaenoic acid (DHA) intake and lower rates of early preterm birth, low birth weight and very low birth weight. ->
|
![]()
|
3. Target DHA level of 5 percent (of RBC) or higher reduces preterm birth risk, research finds (overview Nutrition Insight 23.1.2019) ->
|
![]()
|
4. DHA Supplementation during Pregnancy and Lactation Affects Infants’ Cellular but Not Humoral Immune Response (Study: 400 mg/day) ->
|
![]()
|
5. A Prenatal DHA Test to Help Identify Women at Increased Risk for Early Preterm Birth: A Proposal (in Nutrients 6.12.2018) ->
|
![]()
|
6. Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. ->
|
![]()
|
7. Tolerable intake level in EFSA Journal 2014. ->
|
![]()
|
8. Official publication EU - 2018. ->
|
![]()
|